StockSelector.com
  Research, Select, & Monitor Wednesday, November 14, 2018 6:58:10 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Allergan plc$162.65($1.22)(.74%)

  Quote | Ranking | Chart | Valuations | Sentiment | News | Earnings | Analysts | More...

Your Target?

  Allergan plc vs Drug Manufacturers/Other

Allergan, Inc. is a provider of eye care and specialty pharmaceutical products throughout the world with products in the eye care pharmaceutical, ophthalmic surgical device, over-the-counter contact lens care, movement disorder, and dermatological markets. Its worldwide consolidated revenues are principally generated by prescription and non-prescription pharmaceutical products in the areas of ophthalmology and skin care, neurotoxins, intraocular lenses and other ophthalmic surgical products, and contact lens care products.




Engaged in the discovery, development, and commercialization of innovative pharmaceuticals for the treatment of many diseases, either directly or indirectly. Directly treating a disease would involve some sort of drug that could attack the infection itself. An indirect treatment may involve a drug that's used to enhance the body's own antibody production so those antibodies can attack the infection themselves. Not only do some of these companies develop drugs for human use, a good number of them also work on animal or plant diseases as well.
 Totals Company Industry
  Sales: $15,940.7 Mil $103,380.7 Mil
  Market Cap: $55,138.4 Mil $356,549.6 Mil
  Analysts Recommendation: Buy Buy

 Averages Company Industry
 Growth
  Historic Revenue: 9.4% 46.3%
  Estimated Revenue: (2.4%) (17.3%)
  Historic Earnings: 21.0% (63.9%)
  Estimated Earnings: .4% 17.0%
  Stock Price (1 Year): (6.7%) 3.6%
  Cash per Share: 18.9% 25.7%
  Dividend: N/A N/A
 Price
  Trailing PE: N/A N/A
  Forward PE: 9.9 33.1
  Price-to-Sales: 3.4 N/A
  Price-to-Book: .7 5.9
  Dividend Yield: N/A N/A
  Market Cap: $55,138.4 Mil $12,294.8 Mil
  Operations
  Net Margin: 37.3% (240.3%)
  Gross Margin: 86.4% 83.3%
  Return on Equity: (.1) (1.5)
  Return on Assets: (.0) (.2)
  Balance Sheet
  Current Ratio: 1.2 5.5
  Quick Ratio: 1.1 5.3
  Cash Ratio: .7 4.7
  Debt-to-Equity: .6 2.8
  Interest Coverage: (3.1) .7
 Technicals
  Relative-Strength Index: 32.7 N/A

 Other companies in Drug Manufacturers/Other Price Market Cap
  Novo Nordisk A\/S  (NVO) $44.19 $106,904.4 Mil
  UBS AG  (UBS) $13.64 $53,110.8 Mil
  Vertex Pharmaceuticals Inc.  (VRTX) $170.31 $44,244.5 Mil
  Alexion Pharmaceuticals, Inc.  (ALXN) $118.52 $26,619.6 Mil
  Teva Pharmaceutical Industries, Ltd  (TEVA) $23.53 $23,953.5 Mil






Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.